These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7935506)

  • 21. Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus.
    Deliyannis G; Jackson DC; Ede NJ; Zeng W; Hourdakis I; Sakabetis E; Brown LE
    J Virol; 2002 May; 76(9):4212-21. PubMed ID: 11932386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method for the synthesis of highly pure vaccines using the lipid core peptide system.
    Moyle PM; Olive C; Good MF; Toth I
    J Pept Sci; 2006 Dec; 12(12):800-7. PubMed ID: 17131293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL.
    Deprez B; Sauzet JP; Boutillon C; Martinon F; Tartar A; Sergheraert C; Guillet JG; Gomard E; Gras-Masse H
    Vaccine; 1996 Apr; 14(5):375-82. PubMed ID: 8735547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.
    Bartlett JA; Wasserman SS; Hicks CB; Dodge RT; Weinhold KJ; Tacket CO; Ketter N; Wittek AE; Palker TJ; Haynes BF
    AIDS; 1998 Jul; 12(11):1291-300. PubMed ID: 9708408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
    Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
    J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations.
    Metzger J; Wiesmüller KH; Schaude R; Bessler WG; Jung G
    Int J Pept Protein Res; 1991 Jan; 37(1):46-57. PubMed ID: 2045219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of synthetic peptidic constructs for the vaccine development against viral infections.
    Haro I; Gómara MJ
    Curr Protein Pept Sci; 2004 Dec; 5(6):425-33. PubMed ID: 15581414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes.
    Boeckler C; Frisch B; Muller S; Schuber F
    J Immunol Methods; 1996 May; 191(1):1-10. PubMed ID: 8642195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses.
    Ridgely SL; McGuire TC
    Vaccine; 2002 Mar; 20(13-14):1809-19. PubMed ID: 11906769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.
    Frangione-Beebe M; Albrecht B; Dakappagari N; Rose RT; Brooks CL; Schwendeman SP; Lairmore MD; Kaumaya PT
    Vaccine; 2000 Dec; 19(9-10):1068-81. PubMed ID: 11137241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel version of Multiple Antigenic Peptide allowing incorporation on a cysteine functionalized lysine tree.
    Baleux F; Dubois P
    Int J Pept Protein Res; 1992 Jul; 40(1):7-12. PubMed ID: 1385347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
    Nardin EH; Calvo-Calle JM; Oliveira GA; Clavijo P; Nussenzweig R; Simon R; Zeng W; Rose K
    Vaccine; 1998 Apr; 16(6):590-600. PubMed ID: 9569470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of a complete synthetic peptide-based AIDS vaccine with a built-in adjuvant.
    Nardelli B; Defoort JP; Huang W; Tam JP
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1405-7. PubMed ID: 1466968
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations.
    Newman MJ; Wu JY; Gardner BH; Anderson CA; Kensil CR; Recchia J; Coughlin RT; Powell MF
    Vaccine; 1997 Jun; 15(9):1001-7. PubMed ID: 9261947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen.
    White WI; Cassatt DR; Madsen J; Burke SJ; Woods RM; Wassef NM; Alving CR; Koenig S
    Vaccine; 1995 Aug; 13(12):1111-22. PubMed ID: 7491819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unprotected peptides as building blocks for branched peptides and peptide dendrimers.
    Spetzler JC; Tam JP
    Int J Pept Protein Res; 1995 Jan; 45(1):78-85. PubMed ID: 7775011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine.
    Pöltl-Frank F; Zurbriggen R; Helg A; Stuart F; Robinson J; Glück R; Pluschke G
    Clin Exp Immunol; 1999 Sep; 117(3):496-503. PubMed ID: 10469053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study.
    Le Gal FA; Prevost-Blondel A; Lengagne R; Bossus M; Farace F; Chaboissier A; Gras-Masse H; Engelhard VH; Guillet JG; Gahéry-Ségard H
    Int J Cancer; 2002 Mar; 98(2):221-7. PubMed ID: 11857412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.
    Roth A; Espuelas S; Thumann C; Frisch B; Schuber F
    Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens.
    Phillips NC; Gagné L; Ivanoff N; Riveau G
    Vaccine; 1996 Jun; 14(9):898-904. PubMed ID: 8843632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.